MPP5 binds SARS-CoV-2 E pentamer

Stable Identifier
R-HSA-9705681
Type
Reaction [binding]
Species
Homo sapiens
Related Species
Severe acute respiratory syndrome coronavirus 2
Compartment
ReviewStatus
5/5
Locations in the PathwayBrowser
General
SVG |   | PPTX  | SBGN
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout
This SARS-CoV-2 event was manually inferred from the interaction of homologous SARS-CoV-1 E protein with human MAGUK p55 subfamily member 5 (MPP5, also known as PALS1).

MPP5 (PALS1), a tight junction-associated protein, is a member of the CRUMBS3:MPP5:PATJ polarity complex, which is crucial for the establishment and maintenance of epithelial polarity in mammals. MPP5 has multiple protein-protein interaction domains including a PSD-95/Dlg/ZO-1 (PDZ) domain. A functional PDZ domain-binding motif has been identified at the carboxy-terminus end of SARS-CoV-1 E (Teoh KT et al. 2010; Jimenez-Guardeño JM et al. 2014) and SARS-CoV-2 E (Caillet-Saguy C et al. 2021; Chai J et al. 2021; Shepley-McTaggart A et al. 2021). SARS-CoV-2 E and SARS-CoV-1 E are abundantly expressed inside the infected cell and actively involved in the pathogenic viral mechanisms (Venkatagopalan P et al. 2015; Wong NA & Saier MH Jr 2021). The viral E localizes to the endoplasmic reticulum-Golgi intermediate compartment (ERGIC) for viral assembly and budding. NMR spectroscopy identified the pentameric structure of transmembrane domain of SARS‐CoV‐2 E protein in lipid bilayers (Mandala VS et al. 2020). Infection with recombinant SARS-CoV-1 lacking an E protein PDZ domain-binding motif was attenuated in mice, which was accompanied by a decreased expression of inflammatory cytokines during infection, and a substantial increase of survival (Jimenez-Guardeño JM et al. 2014). SARS-CoV-1 E was found to interfere with host PDZ‐dependent interactions of MPP5 affecting cellular mechanisms thus favoring viral replication (Teoh KT et al. 2010). Coimmunoprecipitation and pull-down assays showed that the viral E protein interacted with MPP5 in human embryonic kidney 293T (HEK293T) and African green monkey kidney Vero E6 cells (Teoh KT et al. 2010). The last four carboxy-terminal amino acids (DLLV) of E interacted with the PDZ domain of MPP5 (Teoh KT et al. 2010). Immunofluorescence assay showed that MPP5 was mainly localized at cell-cell junctions in monolayers of non infected Vero E6 cells, while the binding of SARS-CoV-1 E to MPP5 (PALS1) redistributed MPP5 from the tight junctions of the lung epithelium to the ER-Golgi intermediate compartment (ERGIC) where E assembles in SARS-CoV-1-infected Vero E6 cells (Teoh KT et al. 2010). Ectopic expression of E in madin-darby canine kidney II (MDCKII) epithelial cells significantly altered cyst morphogenesis and, furthermore, delayed formation of tight junctions, affected polarity, and modifies the subcellular distribution of MPP5, in a PDZ-binding motif-dependent manner (Teoh KT et al. 2010). Altogether, these findings suggest that SARS-CoV-1 E interacts with MPP5 (PALS1) and most likely retains MPP5 at the virus assembly site in mammalian cells. However, the relevance of this interaction during virus infection and its impact on virulence in vivo was not tested.

A sequence comparison of the E proteins of the pathogenic human CoVs, SARS-CoV-1, MERS-CoV, and SARS-CoV-2, demonstrated a very high sequence similarity between SARS-CoV-1 E and SARS-CoV-2 E (Grifoni A et al. 2020; Schoeman D & Fielding BC 2020; Hassan SS et al. 2020). This similarity is not shared with the MERS-CoV E protein (Schoeman D & Fielding BC 2020). In silico structural modelling and analyses of E proteins suggested a strengthened binding of SARS-CoV-2 E protein with MPP5 (De Maio F et al. 2020). Equilibrium and kinetic binding experiments of peptides mimicking the E protein of SARS-CoV-1 and SARS-CoV-2 to the PDZ domain of MPP5 further support the hypothesis that the increased virulence of SARS-CoV-2 compared to SARS-CoV-1 may rely on the increased affinity of its E protein for MPP5 (Toto A et al. 2020). However, these binding affinity measurements (Toto A et al. 2020) differ from the findings that the C-terminal PDZ binding motifs of SARS-CoV-1 and SARS-CoV-2 E proteins bind the MPP5 PDZ domain with comparable affinities (Javorsky A et al. 2021). Further, structural studies of the SARS-CoV-2 E:MPP5 complex revealed that the C-terminal DLLV motif of E recognizes a pocket formed by hydrophobic residues from the PDZ and SH3 domains of MPP5 (PALS1) (Chai J et al. 2021; Javorsky A et al. 2021). Similar structural data were reported for the SARS-CoV-1 E protein (Javorsky A et al. 2021).

This Reactome event shows interaction between SARS-CoV-2 E pentamer and human MPP5.

Literature References
PubMed ID Title Journal Year
20861307 The SARS coronavirus E protein interacts with PALS1 and alters tight junction formation and epithelial morphogenesis

Margolis, B, Liu, CJ, Teoh, KT, Bruzzone, R, Nal, B, Peiris, JS, Chan, WL, Siu, YL, Schlüter, MA

Mol. Biol. Cell 2010
34117354 Structural basis of coronavirus E protein interactions with human PALS1 PDZ domain

Kvansakul, M, Humbert, PO, Javorsky, A

Commun Biol 2021
32891874 Improved binding of SARS-CoV-2 Envelope protein to tight junction-associated PALS1 could play a key role in COVID-19 pathogenesis

Roncada, P, De Maio, F, Scambia, G, Babini, G, Urbani, A, Tilocca, B, Sanguinetti, M, Arcovito, A, Della Longa, S, Sali, M, Lo Cascio, E

Microbes Infect 2020
32822073 Comparing the binding properties of peptides mimicking the Envelope protein of SARS-CoV and SARS-CoV-2 to the PDZ domain of the tight junction-associated PALS1 protein

Malagrinò, F, Toto, A, Pagano, L, Stromgaard, K, Ma, S, Gianni, S, Visconti, L

Protein Sci 2020
Participants
Participates
Inferred From
Disease
Name Identifier Synonyms
COVID-19 DOID:0080600 2019 Novel Coronavirus (2019-nCoV), Wuhan seafood market pneumonia virus infection, 2019-nCoV infection, Wuhan coronavirus infection
Authored
Reviewed
Created
Cite Us!